Neograft Technologies focuses on developing cardiac technologies for use the heart bypass procedures.
Neograft Technologies focuses on developing cardiac technologies for use in heart bypass procedures. The company's products include Angioshield, a device for the delivery of controlled temporary structural support to veins intended for use as arterial vein grafts.It was founded in 2009 and headquartered in Taunton, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 16, 2014 | Series Unknown | $11M | 1 | MAG Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
MAG Ventures | Yes | Series Unknown |